Endometriosis in Adolescents VOL. 105, NO. 4, APRIL 2005 OBGY R1 LEE EUN SUK ACOG Committee Opinion...
-
Upload
shannon-cain -
Category
Documents
-
view
215 -
download
1
Transcript of Endometriosis in Adolescents VOL. 105, NO. 4, APRIL 2005 OBGY R1 LEE EUN SUK ACOG Committee Opinion...
Endometriosis in AdolescentsEndometriosis in Adolescents
VOL. 105, NO. 4, APRIL 2005
OBGY R1 LEE EUN SUK
ACOG Committee Opinion Number 310
Endometriosis in AdolescentsEndometriosis in Adolescents
Abstract Historically thought of as a disease that affects adults women, endometriosis increasing is being diagnosed in the
adolescents population
This disorder, which was originally described more than a century ago, still represents a vague and perplexing entity that frequently results in chronic pelvic pain, adhesive disease, and infertility
The purpose of this Committee Opinion is to highlight the differences in adolescent and adult types of endometriosis
Early diagnosis and treatment during adolescence may decrease
disease progression and prevent subsequent infertility
Endometriosis in AdolescentsEndometriosis in Adolescents
Incidence
Goldstein et al : 47% prevalence of endometriosis in adolescent females with pelvic pain
50-70% of adolescents with pelvic pain not responding to combination hormone therapy and NSAIDs have endomeriosis
Endometriosis has been identified in premenarcheal girls who have started puberty and have some breast development
Endometriosis in AdolescentsEndometriosis in Adolescents
Theory of endometriosis
Ectopic transplantation of endometrial tissue
Endometriosis caused by the seeding or implantation of endometrial cells by transtubal regurgitation during menstruation
Coelomic metaplasia
Transformation (metaplasia) of coelomic epithelium into endometrial tissue
Induction theory
Extension of the coelomic metaplasia theory
Endogenous (undefined) biochemical factor → undifferentiated peritoneal cells to develop into endometrial tissue
Endometriosis in AdolescentsEndometriosis in Adolescents
Incidence
66% of adults women reported the onset of pelvic symptoms before age 20 years
As the age of the onset of symptoms decreases, the number of doctors reaching a diagnosis increases
With early diagnosis and treatment, it is hoped that disease progression and infertility can be limited
Endometriosis in AdolescentsEndometriosis in Adolescents
Presentation and Characteristics
Adolescents primarily seek medical attention because of pain rather than a concern for infertility
Common symptoms Progressive dysmenorrhea (64-94%) Acyclic pain (36-91%) Dyspareunia (2-46%) Gastrointestinal complaints (2-46%)
Endometriosis in AdolescentsEndometriosis in Adolescents
Diagnosis
History and Physical examination → Differential diagnosis of pelvic pain
Appendicitis Pelvic inflammatory disease Mullerian anomalies or outflow obstruction Bowel disease Hernia Musculoskeletal disorder Psychosocial complaints
Endometriosis in AdolescentsEndometriosis in Adolescents
Diagnosis
Pelvic examination may be difficult, especially in patients who have not had vaginal intercourse
Rectal –abdominal examination in the dorsal lithotomy position may be helpful to determine if a pelvic mass is present
Cotton-tipped swab to evaluate for the presence of transverse vaginal septum, or agenesis of the lower vagina
Ultrasound examination is helpful in evaluation the pelvis of young adolescents who declines a bimanual or rectal-abdominal exam
Endometriosis in AdolescentsEndometriosis in Adolescents
Diagnosis
Imaging studies and serum markers
Ultrasonography & magnetic resonance imaging → Evaluate anatomical structures
CA125 → very sensitive but not specific
Endometriosis in AdolescentsEndometriosis in Adolescents
Empiric therapy
Younger than 18 years → Combination hormone therapy and NSAIDs
Older than 18 years → Empiric trial of GnRH agonist therapy
For patients younger than 18 years because of the effects of GnRH agonist medications on bone formation & long-term bone density or who decline empiric therapy
→ Diagnostic and therapeutic laparoscopy
Endometriosis in AdolescentsEndometriosis in Adolescents
Surgical diagnosis
After a comprehensive preoperative evaluation and trial of combination hormone therapy and NSAIDs
→ Diagnostic and therapeutic laparoscopy
Laparoscopic findings
Inspection and palpation with a blunt probe of the bowel, bladder, uterus, tubes, ovaries, cul-de-sac, and broad ligament
Typical lesions of endometriosis in adolescents : Red, clear, or white as opposed to the powder-burn lesion seen commonly in adults
Histologic confirmation of the laparoscopic impression is essential for the diagnosis of endometriosis
Endometriosis in AdolescentsEndometriosis in Adolescents
Mullerian Anomalies and Endometriosis
Incidence of anomalies of the reproductive system
Most studies quote the rate of 5-6%
Clinical outcome in patients with outflow tract obstructions differ from those without such obstructions
Because regression of disease usually has been observed once surgical correction of the anomaly has been accomplished
Endometriosis in AdolescentsEndometriosis in Adolescents
Treatment
Surgery, hormonal manipulation, pain medications, mental health support, complementary and alternative therapies, and
education
For patients younger than 18 years with persistent pelvic pain Combination hormone therapy & laparoscopic procedure Only procedures that preserve fertility options should be applied After surgery adolescents should be treated with medical therapy until childbearing
The goal of therapy Suppression of pain Suppression of disease progression Preservation of fertility
Endometriosis in AdolescentsEndometriosis in Adolescents
Treatment
First-line treatment modalities → NSAID & hormone therapy
Continuous combination hormone therapy
OCPs, combinations hormonal contraceptive patch, or vaginal ring for menstrual suppression
Oral contraceptives
Low dose monophasic combination contraceptives (one pill per day for 6 to 12 months) to induce 'pseudopregnancy' caused by the resultant amenorrhea & decidualization of endometrial tissue
Endometriosis in AdolescentsEndometriosis in Adolescents
Treatment
Progestins
Antiendometriotic effect by causing initial decidualization of endometrial tissue followed by atrophy
Medroxyprogesterone acetate starting at a dose of 30mg/day Increasing the dose based on the clinical response & bleeding patterns
Side effect : nausea, weight gain, fluid retention, breakthrough bleeding due to hypoestrogenemia
Endometriosis in AdolescentsEndometriosis in Adolescents
Treatment
Danazol ( Androgenic & antiestrogenic agents)
Suppression of GnRH or gonadotropin secretion
Direct inhibition of steroidogenesis
Direct antagonistic and agonistic interaction with endometrial androgen & progesterone receptors
Dose : absence of menstruation is a better indicator of response than drug dose start with 400mg daily (200mg twice a day) & increase the dos
e to achieve amenorrhea and relieve symptoms
Side effect : weight gain, fluid retention, acne, oily skin, hirsuitism, hot flashes, atrophic vaginitis, reduced breast size, reduced libido, fatigue, nausea, muscle cramps, emotional instability
Endometriosis in AdolescentsEndometriosis in Adolescents
Treatment
GnRH agonists
Hypoestrogenic state by down-regulating hypothalamic-pituitary axis
Cause a loss of pituitary receptors & downregulation of GnRH activity, resulting in low FSH & LH level → pseudomenopause
Limited to 6 months because of resultant profound hypoestrogenic state & subsequent effect on bone mineralization
Side effect : hot flashes, vaginal dryness, ↓libido, osteoporosis (add-back regimen)
Endometriosis in AdolescentsEndometriosis in Adolescents
Treatment
GnRH agonists
Add-back therapy
Norethindrone acetate (15mg per day) or conjugated estrogens/ medroxyprogesterone acetate (0.625/2.5mg per day) to reduce bone loss related to a hypoestrogenic state
→ Preserve bone density
Endometriosis in AdolescentsEndometriosis in Adolescents
Surgery for the management of endometriosis-related pain
Important option for adolescents, but clearly, radical procedures (oophorectomy, bilateral oophorectomy, or hysterectomy)
should be avoided in this age group
In patients with severe endometriosis
Surgical treatment be preceded by a 3 month course of medical treatment to reduce vascularization and nodular size
Postoperative hormone replacement with estrogen & progesterone
Required after bilateral oophorectomy The risk of renewed growth of residual endometriosis → Hormonal replacement therapy withheld until 3months after surgery
Endometriosis in AdolescentsEndometriosis in Adolescents
Summary
Adolescent patients typically present with progressive and severe dysmenorrhea, but also may present with acyclic pelvic pain
Standard therapy (combination hormone therapy and NSAIDs) for dysmenorrhea should be initiated, if symptoms do not resolve after 3 months further evaluation for endometriosis is indicated
A bimanual pelvic examination may be difficult : cotton-tipped swab to evaluate for the presence of transverse vaginal septum, or agenesis of the lower vagina : ultrasound exam in evaluation the pelvis of adolescents Endometriosis in adolescents typically presents as early disease & clear, red, and white lesions are the most common
Endometriosis in AdolescentsEndometriosis in Adolescents
Summary
Treatment should focus on conservative measures with surgical
& medical interventions
Only procedures that preserve fertility options be applied
Because there is no cure for endometriosis, long-term treatment should continue until desired family size is reached or fertility no longer needs to be preserved